IT1393524B1 - Contenitore per uso farmaceutico atto al rilascio quantitativo di una monodose per somministrazione orale di ormoni tiroidei t3 e t4 in soluzione - Google Patents

Contenitore per uso farmaceutico atto al rilascio quantitativo di una monodose per somministrazione orale di ormoni tiroidei t3 e t4 in soluzione

Info

Publication number
IT1393524B1
IT1393524B1 ITMI2009A000118A ITMI20090118A IT1393524B1 IT 1393524 B1 IT1393524 B1 IT 1393524B1 IT MI2009A000118 A ITMI2009A000118 A IT MI2009A000118A IT MI20090118 A ITMI20090118 A IT MI20090118A IT 1393524 B1 IT1393524 B1 IT 1393524B1
Authority
IT
Italy
Prior art keywords
ormones
thyroidal
container
solution
oral administration
Prior art date
Application number
ITMI2009A000118A
Other languages
English (en)
Inventor
Antonio Fontana
Giorgio Zoppetti
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Priority to ITMI2009A000118A priority Critical patent/IT1393524B1/it
Priority to EP09779078A priority patent/EP2391331A1/en
Priority to CN2009801558597A priority patent/CN102300542A/zh
Priority to PCT/EP2009/051984 priority patent/WO2010086030A1/en
Priority to US12/388,691 priority patent/US20100197790A1/en
Publication of ITMI20090118A1 publication Critical patent/ITMI20090118A1/it
Application granted granted Critical
Publication of IT1393524B1 publication Critical patent/IT1393524B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01H—ELECTRIC SWITCHES; RELAYS; SELECTORS; EMERGENCY PROTECTIVE DEVICES
    • H01H1/00—Contacts
    • H01H1/12—Contacts characterised by the manner in which co-operating contacts engage
    • H01H1/14—Contacts characterised by the manner in which co-operating contacts engage by abutting
    • H01H1/22—Contacts characterised by the manner in which co-operating contacts engage by abutting with rigid pivoted member carrying the moving contact
    • H01H1/221—Contacts characterised by the manner in which co-operating contacts engage by abutting with rigid pivoted member carrying the moving contact and a contact pressure spring acting between the pivoted member and a supporting member
    • H01H1/225—Contacts characterised by the manner in which co-operating contacts engage by abutting with rigid pivoted member carrying the moving contact and a contact pressure spring acting between the pivoted member and a supporting member the supporting member being pivotable
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01H—ELECTRIC SWITCHES; RELAYS; SELECTORS; EMERGENCY PROTECTIVE DEVICES
    • H01H1/00—Contacts
    • H01H1/12—Contacts characterised by the manner in which co-operating contacts engage
    • H01H1/14—Contacts characterised by the manner in which co-operating contacts engage by abutting
    • H01H1/22—Contacts characterised by the manner in which co-operating contacts engage by abutting with rigid pivoted member carrying the moving contact
    • H01H1/221—Contacts characterised by the manner in which co-operating contacts engage by abutting with rigid pivoted member carrying the moving contact and a contact pressure spring acting between the pivoted member and a supporting member
    • H01H2001/223—Contacts characterised by the manner in which co-operating contacts engage by abutting with rigid pivoted member carrying the moving contact and a contact pressure spring acting between the pivoted member and a supporting member using a torsion spring
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01H—ELECTRIC SWITCHES; RELAYS; SELECTORS; EMERGENCY PROTECTIVE DEVICES
    • H01H71/00—Details of the protective switches or relays covered by groups H01H73/00 - H01H83/00
    • H01H71/10—Operating or release mechanisms
    • H01H71/1009—Interconnected mechanisms
    • H01H2071/1036—Interconnected mechanisms having provisions for four or more poles
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01H—ELECTRIC SWITCHES; RELAYS; SELECTORS; EMERGENCY PROTECTIVE DEVICES
    • H01H71/00—Details of the protective switches or relays covered by groups H01H73/00 - H01H83/00
    • H01H71/10—Operating or release mechanisms
    • H01H71/1009—Interconnected mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI2009A000118A 2009-01-30 2009-01-30 Contenitore per uso farmaceutico atto al rilascio quantitativo di una monodose per somministrazione orale di ormoni tiroidei t3 e t4 in soluzione IT1393524B1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI2009A000118A IT1393524B1 (it) 2009-01-30 2009-01-30 Contenitore per uso farmaceutico atto al rilascio quantitativo di una monodose per somministrazione orale di ormoni tiroidei t3 e t4 in soluzione
EP09779078A EP2391331A1 (en) 2009-01-30 2009-02-19 Container for pharmaceutical use for the quantitative release of a single dose for oral administration of t3 and t4 thyroid hormones in solution
CN2009801558597A CN102300542A (zh) 2009-01-30 2009-02-19 一种用于定量释放单剂量的用于口服的t3和t4甲状腺激素溶液的药用容器
PCT/EP2009/051984 WO2010086030A1 (en) 2009-01-30 2009-02-19 Container for pharmaceutical use for the quantitative release of a single dose for oral administration of t3 and t4 thyroid hormones in solution
US12/388,691 US20100197790A1 (en) 2009-01-30 2009-02-19 Container for pharmaceutical use for the quantitative release of a single dose for oral administration of t3 and t4 thyroid hormones in solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A000118A IT1393524B1 (it) 2009-01-30 2009-01-30 Contenitore per uso farmaceutico atto al rilascio quantitativo di una monodose per somministrazione orale di ormoni tiroidei t3 e t4 in soluzione

Publications (2)

Publication Number Publication Date
ITMI20090118A1 ITMI20090118A1 (it) 2010-07-31
IT1393524B1 true IT1393524B1 (it) 2012-04-27

Family

ID=41139334

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A000118A IT1393524B1 (it) 2009-01-30 2009-01-30 Contenitore per uso farmaceutico atto al rilascio quantitativo di una monodose per somministrazione orale di ormoni tiroidei t3 e t4 in soluzione

Country Status (5)

Country Link
US (1) US20100197790A1 (it)
EP (1) EP2391331A1 (it)
CN (1) CN102300542A (it)
IT (1) IT1393524B1 (it)
WO (1) WO2010086030A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20112066A1 (it) * 2011-11-14 2013-05-15 Altergon Sa Preparazione farmaceutica orale monodose di ormoni tiroidei t3 e t4
ITMI20131008A1 (it) * 2013-06-18 2014-12-19 Altergon Sa Dispositivo monodose spray per applicazioni topiche e sistemiche
US10266228B2 (en) 2016-06-24 2019-04-23 Easy2.Company B.V. Drive train for a treadle scooter
EP3311844A1 (en) 2016-10-18 2018-04-25 Altergon S.A. High-stability packaged solutions of t4 thyroid hormone
IT201900003013A1 (it) * 2019-03-01 2020-09-01 Altergon Sa Regime di somministrazione di composizioni di ormone tiroideo T4 con elevato assorbimento orale
US11241382B2 (en) 2019-03-01 2022-02-08 Altergon Sa Administration regimen of compositions of T4 thyroid hormone with high oral absorption

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB967334A (it) * 1960-04-27
US3975463A (en) * 1971-06-18 1976-08-17 Toyo Seikan Kaisha Limited Molded structures containing crystalling polyolefin saponified ethylene vinyl acetate copolymer and carbonyl containing copolymers
US4116914A (en) * 1977-02-14 1978-09-26 Monsanto Company Elastoplastic compositions of ethylene-vinyl acetate rubber and polyolefin resin
US5271881A (en) * 1987-09-28 1993-12-21 Redding Bruce K Apparatus and method for making microcapsules
US5965164A (en) * 1994-10-28 1999-10-12 Fuisz Technologies Ltd. Recipient-dosage delivery system
US6245350B1 (en) * 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US5843540A (en) * 1996-11-15 1998-12-01 Tetra Laval Holdings & Finance, S.A. Multi-layer flexible container for flowable materials
US6730735B2 (en) * 1997-07-03 2004-05-04 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Conjugate of polyethylene glycol and chitosan
MXPA03001854A (es) * 2000-08-29 2004-12-03 Nisshin Kasei Co Ltd Capsula dura.
DE20019365U1 (de) * 2000-11-15 2001-01-18 Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, 13581 Berlin Eindosis-Kunststoffbehältnis zur Aufnahme von einem flüssigen oder gelartigen pharmazeutischen Präparat
DE60212354T2 (de) * 2001-02-01 2007-11-29 American Renolit Corp.LA, , City of Commerce Flexible, seps enthaltende, elastomerfilme und medizinische behälter
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
ATE396744T1 (de) * 2001-10-23 2008-06-15 Innogel Ag Netzwerk auf polysaccharidbasis und verfahren zu dessen herstellung
JP2006521427A (ja) * 2003-03-28 2006-09-21 イノゲル アクチエンゲゼルシヤフト 靱性−弾性材料
JP4412463B2 (ja) * 2003-12-11 2010-02-10 藤森工業株式会社 複室容器

Also Published As

Publication number Publication date
EP2391331A1 (en) 2011-12-07
ITMI20090118A1 (it) 2010-07-31
CN102300542A (zh) 2011-12-28
WO2010086030A1 (en) 2010-08-05
US20100197790A1 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
IL268756B (en) Piperazine-2,5-dione derivatives, pharmaceutical preparations containing them and their use for the preparation of medicines
SMT201600258B (it) Composto indolico e suo uso farmaceutico
IT1393524B1 (it) Contenitore per uso farmaceutico atto al rilascio quantitativo di una monodose per somministrazione orale di ormoni tiroidei t3 e t4 in soluzione
IT1393082B1 (it) Struttura di imballo di contenitori ad uso farmaceutico
BR112012013148A2 (pt) formulação farmacêutica e uso
CL2014000370A1 (es) Hemifumarato de tenofovir alafenamida; metodo de preparación; composicion farmaceutica que lo comprende; metodo para preparar la composicion farmaceutica; y uso en el tratamiento de una infeccion por hiv.
CO6900149A2 (es) Una composición farmacéutica que comprende los fitocanabinoides canabidivarina (cbdv) y canabidiol (cbd)
CO6890098A2 (es) Compuesto pirazol y su uso farmaceutico
BR112013019152A2 (pt) conector hermético, perfurável sem agulha e automaticamente resselável, para dispositivos a serem usados para coletar e administrar soluções líquidas para uso farmacêutico e/ou nutricional
HN2011003072A (es) Sales de disacarina, ácido difumárico, ácido d1-1-hidroxi-2-naftoico y ácido monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino)pirimidin-5-il)metil)fenil)acetato de 4-(demitilamino)butilo
DK2399626T3 (da) Føler til brug i anlæg til udlevering af flydende lægemidler
CL2014001016A1 (es) Compuestos triciclicos condensados y sus sales farmaceuticamente aceptables; composicion farmaceutica que los comprende; y su uso en el tratamiento de una infeccion viral.
BRPI1011453A2 (pt) formulacao, forma de dosagem de um medicamento, e, sal de hemipamoato de asenapina
DK2773397T3 (da) Stempel til en patron til anvendelse i en medicinafgivelsesanordning
DK2482886T3 (da) Anordning til brug i en medikamentafgivelsesindretning
CL2014001337A1 (es) Formulacion farmaceutica oral solida que comprende una dispersion solida que comprende a su vez un compuesto especifico derivado de 4-(1-isopropil-1h-pirazol-4-il)-pirimidina y su uso en el tratamiento de una enfermedad proliferativa.
CO6801754A2 (es) Una composición farmacéutica para tratar una enfermedad en la cavidad oral que comprende rebamipida
BR112014002845A2 (pt) “composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto”
BR112013010043A2 (pt) formulação farmacêutica na forma de filme e uso de uma combinação de excipientes farmacêuticas aceitáveis.
CL2014000895A1 (es) Compuestos derivados de {2-cloro-4-[hidroxi(cicloalquil/heterociclil)]amino]fenil}acetonitrilo, moduladores selectivos del receptor androgeno; composicion farmaceutica; composicion farmceutica que comprende una forma cristalina; y su uso en el tratamiento de la atrofia muscular
ECSP13012832A (es) Compuestos de pirazol como antagonistas de crth2
CL2014003484A1 (es) Uso de nalmefeno en la reduccion del consumo de alcohol en un paciente con dependencia del alcohol; composicion farmaceutica oral; combinacion farmaceutica.
HK1150340A1 (en) The use of a traditional chinese medicine composition in the preparation of anti-influenza virus drugs
HK1249848A1 (zh) 親脂性物質的水溶液，特別是藥物物質溶液
BRPI1009116A2 (pt) solução eletrolítica aquosa equilibrada, processo para preparação e seu uso, mistura eletrolítica e medicamento